Request Your Free White Paper Now:
"The Pancreatic Cancer Action Network Increases Biomarker-Driven Clinical Trial Matching Capabilities by nearly 300% with GenomOncology."
"The Pancreatic Cancer Action Network Increases Biomarker-Driven Clinical Trial Matching Capabilities by nearly 300% with GenomOncology."
Learn how the Pancreatic Cancer Action Network (PanCAN) utilized GenomOncology’s Clinical Trial Matching solution to streamline the organization’s biomarker-driven clinical trial matching process.
Read more about:
- The challenges associated with utilizing the ever-evolving precision medicine data in patient treatment matching, and how GenomOncology’s clinical trial matching solution navigates through this growing data in order to streamline the matching of patients to accurate, relevant clinical trials.
- How GenomOncology enabled PanCAN to increase the number of biomarker-driven searches by 300% and reduce the time spent on biomarker-driven clinical trial searches by 50%.
- PanCAN’s upgrade to GenomOncology’s Precision Decision, which enables the PanCAN team to advance their treatment searching capabilities through the addition of the patient's prior intervention history.
Offered Free by: GenomOncology
See All Resources from: GenomOncology
Recommended for Professionals Like You:
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
